Cargando…

Muscleblind-Like 1 Knockout Mice Reveal Novel Splicing Defects in the Myotonic Dystrophy Brain

Myotonic dystrophy type 1 (DM1) is a multi-systemic disorder caused by a CTG trinucleotide repeat expansion (CTG(exp)) in the DMPK gene. In skeletal muscle, nuclear sequestration of the alternative splicing factor muscleblind-like 1 (MBNL1) explains the majority of the alternative splicing defects o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suenaga, Koichi, Lee, Kuang-Yung, Nakamori, Masayuki, Tatsumi, Yoshiki, Takahashi, Masanori P., Fujimura, Harutoshi, Jinnai, Kenji, Yoshikawa, Hiroo, Du, Hongqing, Ares, Manuel, Swanson, Maurice S., Kimura, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302840/ https://www.ncbi.nlm.nih.gov/pubmed/22427994 http://dx.doi.org/10.1371/journal.pone.0033218

Ejemplares similares

Differences in splicing defects between the grey and white matter in myotonic dystrophy type 1 patients
por: Nishi, Masamitsu, et al.
Publicado: (2020)

Compound loss of muscleblind-like function in myotonic dystrophy
por: Lee, Kuang-Yung, et al.
Publicado: (2013)

Altered levels of the splicing factor muscleblind modifies cerebral cortical function in mouse models of myotonic dystrophy
por: Chen, Gang, et al.
Publicado: (2018)

Optical Mapping Approaches on Muscleblind‐Like Compound Knockout Mice for Understanding Mechanistic Insights Into Ventricular Arrhythmias in Myotonic Dystrophy
por: Chou, Chung‐Chuan, et al.
Publicado: (2017)

Zebrafish deficient for Muscleblind-like 2 exhibit features of myotonic dystrophy
por: Machuca-Tzili, Laura E., et al.
Publicado: (2011)

Muscleblind, BSF and TBPH are mislocalized in the muscle sarcomere of a Drosophila myotonic dystrophy model
por: Llamusi, Beatriz, et al.
Publicado: (2013)

Transcriptome alterations in myotonic dystrophy frontal cortex
por: Otero, Brittney A., et al.
Publicado: (2021)

Muscleblind-like1 Undergoes Ectopic Relocation in the Nuclei of Skeletal Muscles in Myotonic Dystrophy and Sarcopenia
por: Malatesta, M., et al.
Publicado: (2013)

Derepressing muscleblind expression by miRNA sponges ameliorates myotonic dystrophy-like phenotypes in Drosophila
por: Cerro-Herreros, Estefania, et al.
Publicado: (2016)

Cellular Senescence and Aging in Myotonic Dystrophy
por: Hasuike, Yuhei, et al.
Publicado: (2022)

Muscleblind-like 3 deficit results in a spectrum of age-associated pathologies observed in myotonic dystrophy
por: Choi, Jongkyu, et al.
Publicado: (2016)

Oral administration of erythromycin decreases RNA toxicity in myotonic dystrophy
por: Nakamori, Masayuki, et al.
Publicado: (2015)

Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy
por: Freyermuth, Fernande, et al.
Publicado: (2016)

Muscleblind1, but Not Dmpk or Six5, Contributes to a Complex Phenotype of Muscular and Motivational Deficits in Mouse Models of Myotonic Dystrophy
por: Matynia, Anna, et al.
Publicado: (2010)

Altered Behavioral Responses Show GABA Sensitivity in Muscleblind-Like 2-Deficient Mice: Implications for CNS Symptoms in Myotonic Dystrophy
por: Edokpolor, Kamyra S., et al.
Publicado: (2022)

Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy
por: Thomas, James D., et al.
Publicado: (2017)

Deterministic splicing of Dscam2 is regulated by Muscleblind
por: Li, Joshua Shing Shun, et al.
Publicado: (2019)

Expanded CUG Repeat RNA Induces Premature Senescence in Myotonic Dystrophy Model Cells
por: Hasuike, Yuhei, et al.
Publicado: (2022)

miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models
por: Cerro-Herreros, Estefania, et al.
Publicado: (2018)

Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs
por: Yuan, Yuan, et al.
Publicado: (2007)

Drosophila Muscleblind Is Involved in troponin T Alternative Splicing and Apoptosis
por: Vicente-Crespo, Marta, et al.
Publicado: (2008)

Targeting nuclear RNA for in vivo correction of myotonic dystrophy
por: Wheeler, Thurman M., et al.
Publicado: (2012)

Conservation of context-dependent splicing activity in distant Muscleblind homologs
por: Oddo, Julia C., et al.
Publicado: (2016)

Abnormal splicing switch of DMD's penultimate exon compromises muscle fibre maintenance in myotonic dystrophy
por: Rau, Frédérique, et al.
Publicado: (2015)

Myotonic dystrophy
por: Patterson, VH
Publicado: (1990)

The Dimeric Form of 1,3‐Diaminoisoquinoline Derivative Rescued the Mis‐splicing of Atp2a1 and Clcn1 Genes in Myotonic Dystrophy Type 1 Mouse Model
por: Matsumoto, Jun, et al.
Publicado: (2020)

Autistic traits in myotonic dystrophy type 1 due to MBNL inhibition and RNA mis-splicing
por: Sznajder, Lukasz, et al.
Publicado: (2023)

Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability
por: Ueki, Junko, et al.
Publicado: (2017)

Quercetin selectively reduces expanded repeat RNA levels in models of myotonic dystrophy
por: Mishra, Subodh K., et al.
Publicado: (2023)

An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I
por: López-Martínez, Andrea, et al.
Publicado: (2020)

Large expansion of CTG•CAG repeats is exacerbated by MutSβ in human cells
por: Nakatani, Rie, et al.
Publicado: (2015)

Cell type-specific abnormalities of central nervous system in myotonic dystrophy type 1
por: Nakamori, Masayuki, et al.
Publicado: (2022)

Cancer and Myotonic Dystrophy
por: D’Ambrosio, Eleonora S., et al.
Publicado: (2023)

Dissecting domains necessary for activation and repression of splicing by muscleblind-like protein 1
por: Edge, Christopher, et al.
Publicado: (2013)

Pharmacotherapy alleviates pathological changes in human direct reprogrammed neuronal cell model of myotonic dystrophy type 1
por: Eltahir, Mougina K., et al.
Publicado: (2022)

Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy
por: Tanner, Matthew K, et al.
Publicado: (2021)

Deregulations of miR‐1 and its target Multiplexin promote dilated cardiomyopathy associated with myotonic dystrophy type 1
por: Souidi, Anissa, et al.
Publicado: (2023)

Straightjacket/α2δ3 deregulation is associated with cardiac conduction defects in myotonic dystrophy type 1
por: Auxerre-Plantié, Emilie, et al.
Publicado: (2019)

Detection of Slipped-DNAs at the Trinucleotide Repeats of the Myotonic Dystrophy Type I Disease Locus in Patient Tissues
por: Axford, Michelle M., et al.
Publicado: (2013)

From dynamic combinatorial ‘hit’ to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy
por: Ofori, Leslie O., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2ohpphvpg58c63umd13bn0g389